Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Synergy CHC Corp.SNYR · Entity 8555 | Director | April 21, 2026 | April 25, 2026 |
| VIEMED HEALTHCARE, INC.VMD · Entity 5824 | Director | August 17, 2026 | August 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Synergy CHC Corp.
Report date April 21, 2026 · Filed April 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.00001 per shareSEC Table I · non-derivative | Direct | 306,433 |
Reported balance
After 2026-04-21 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-04-21 · Grant · Acquired 306,433 · Balance 306,433 F1: The reported securities are restricted stock units ("RSU"). Each RSU represents a contingent right to receive one share of common stock, par value $0.00001 per share, of Synergy CHC Corp. (the "Issuer"), subject to the conditions set forth in the applicable RSU award agreement and Issuer's 2024 Equity Incentive Plan, as amended. The RSUs vested in full on the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities are restricted stock units ("RSU"). Each RSU represents a contingent right to receive one share of common stock, par value $0.00001 per share, of Synergy CHC Corp. (the "Issuer"), subject to the conditions set forth in the applicable RSU award agreement and Issuer's 2024 Equity Incentive Plan, as amended. The RSUs vested in full on the grant date.
VIEMED HEALTHCARE, INC.
Report date August 17, 2026 · Filed August 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 161,361 |
Reported balance
After 2026-08-19 transaction · row 1
1 source rowRow 1 · 2026-08-19 · Exercise / conversion · Acquired 18,786 · Balance 161,361 F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-08-19 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-08-19 · Exercise / conversion · Disposed 18,786 · Balance 0 F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. F2: On August 19, 2025, the reporting person was granted Restricted Stock Units which vest on August 19, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2027-08-17 | Direct | 15,217 |
Reported balance
After 2026-08-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-17 · Grant · Acquired 15,217 · Balance 15,217 F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. F3: On August 17, 2026, the reporting person was granted Restricted Stock Units which vest on August 17, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
F2: On August 19, 2025, the reporting person was granted Restricted Stock Units which vest on August 19, 2026.
F3: On August 17, 2026, the reporting person was granted Restricted Stock Units which vest on August 17, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 09, 2021 Filed May 10, 2021 20:23 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Disposition to issuerCommon Shares | 2,352 | $9.57 | $22,508.64 |
DisclosureSEC source: 0001729149-21-000087 · wf-form4_162067817799254.xml · nonDerivative · entry 2 Kaushal Nitin · CIK 0001782072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,204 Read SEC document |
| May 09, 2021 Filed May 10, 2021 20:23 UTC | VIEMED HEALTHCARE, INC. VMD · Entity 5824 | Exercise / conversionCommon Shares | 2,352 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001729149-21-000087 · wf-form4_162067817799254.xml · nonDerivative · entry 1 Kaushal Nitin · CIK 0001782072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.